Literature DB >> 10081518

Factors predicting clinical remission in adult patients with type 1 diabetes.

A Schölin1, C Berne, E Schvarcz, F A Karlsson, E Björk.   

Abstract

OBJECTIVES: To describe the course of clinical remission in adult patients (16-50 years of age) with type 1 diabetes and to identify factors predictive of the occurrence and length of remission.
DESIGN: A retrospective cohort study.
SUBJECTS: Sixty-two consecutive patients (43 men and 19 women) with new onset IDDM, 27 +/- 8 years at diagnosis and treated with multiple insulin injections from the beginning.
SETTING: Department of Medicine, Uppsala University Hospital and Orebro Medical Centre, Sweden. MAIN OUTCOME MEASURES: Length and occurrence of remission (defined as maintenance of HbA1c < or = 6.5% and an insulin dosage of < or = 0.4 U kg-1 day-1 for a minimum of 1 month) in relation to nine biochemical and clinical factors at diagnosis.
RESULTS: Sixty-one per cent of the patients entered remission. The duration of remission was longer in males than females (10 +/- 12 vs. 2 +/- 3 months; P < 0.01). Male gender, normal serum bicarbonate at onset and a short time of classic symptoms before onset were predictive markers (P < 0.01; P < 0.05 and P < 0.01, respectively) for longer duration of remission. Low serum bicarbonate levels at onset were associated with lower occurrence of remission. Blood glucose, body mass index (BMI), and age at diagnosis did not influence the occurrence or the duration of remission.
CONCLUSIONS: In most adult patients with new onset of type 1 diabetes remission is induced when using multiple insulin injection therapy. Male patients seem particularly prone to remission, and the length and extent of beta-cell strain prior to diagnosis strongly influences its course.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081518     DOI: 10.1046/j.1365-2796.1999.00426.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  15 in total

1.  Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.

Authors:  A Blasetti; C Di Giulio; S Tumini; M Provenzano; D Rapino; L Comegna; G Prezioso; R Chiuri; S Franchini; F Chiarelli; L Stuppia
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

2.  Partial Clinical Remission of Type 1 Diabetes Mellitus in Children: Clinical Applications and Challenges with its Definitions.

Authors:  Benjamin Udoka Nwosu
Journal:  Eur Med J Diabetes       Date:  2019-03-14

3.  Uncommon Presentations of Diabetes: Zebras in the Herd.

Authors:  Karen L Shidler; Lisa R Letourneau; Lucia M Novak
Journal:  Clin Diabetes       Date:  2020-01

4.  β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up.

Authors:  Maria Thunander; Hlin Thorgeirsson; Carina Törn; Christer Petersson; Mona Landin-Olsson
Journal:  Eur J Endocrinol       Date:  2010-11-18       Impact factor: 6.664

5.  A diagnostic approach for defining idiopathic remitting diabetes: a retrospective cohort study.

Authors:  Tarig Babiker; Ali J Chakera; Maggie Shepherd; Andrew T Hattersley
Journal:  BMC Endocr Disord       Date:  2014-06-09       Impact factor: 2.763

6.  Spontaneous complete remission of type 1 diabetes mellitus in an adult - review and case report.

Authors:  Harsha Moole; Vishnu Moole; Adrija Mamidipalli; Sowmya Dharmapuri; Raghuveer Boddireddy; Deepak Taneja; Hady Sfeir; Sonia Gajula
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-10-19

Review 7.  Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.

Authors:  Chunguang Chen; Christian M Cohrs; Julia Stertmann; Robert Bozsak; Stephan Speier
Journal:  Mol Metab       Date:  2017-07-08       Impact factor: 7.422

8.  New definition for the partial remission period in children and adolescents with type 1 diabetes.

Authors:  Henrik B Mortensen; Philip Hougaard; Peter Swift; Lars Hansen; Reinhard W Holl; Hilary Hoey; Hilde Bjoerndalen; Carine de Beaufort; Francesco Chiarelli; Thomas Danne; Eugen J Schoenle; Jan Aman
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 17.152

9.  A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.

Authors:  Katherine R Marino; Rachel L Lundberg; Aastha Jasrotia; Louise S Maranda; Michael J Thompson; Bruce A Barton; Laura C Alonso; Benjamin Udoka Nwosu
Journal:  PLoS One       Date:  2017-05-01       Impact factor: 3.752

10.  Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.

Authors:  Benjamin Udoka Nwosu; Bo Zhang; Sanaa S Ayyoub; Stephanie Choi; Tony R Villalobos-Ortiz; Laura C Alonso; Bruce A Barton
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.